Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

Yoanna Pumpalova, MD People infected with human immunodeficiency virus (HIV) have a substantially higher risk of certain types of cancer -Kaposi ...